Koninklijke Philips N.V. (RYLPF)
USD 24.63
(0.28%)
USD 24.63
(0.28%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 5.74 Billion EUR | -18.28% |
| 2022 | 7.02 Billion EUR | 50.32% |
| 2021 | 4.67 Billion EUR | 26.11% |
| 2020 | 3.7 Billion EUR | -7.81% |
| 2019 | 4.02 Billion EUR | 28.38% |
| 2018 | 3.13 Billion EUR | 12.82% |
| 2017 | 2.77 Billion EUR | -15.13% |
| 2016 | 3.27 Billion EUR | -18.08% |
| 2015 | 3.99 Billion EUR | 79.02% |
| 2014 | 2.23 Billion EUR | 55.36% |
| 2013 | 1.43 Billion EUR | 105.14% |
| 2012 | 700 Million EUR | -1.82% |
| 2011 | 713 Million EUR | 160.68% |
| 2010 | -1.17 Billion EUR | -887.39% |
| 2009 | -119 Million EUR | -120.95% |
| 2008 | 568 Million EUR | 110.88% |
| 2007 | -5.22 Billion EUR | -142.33% |
| 2006 | -2.15 Billion EUR | -167.43% |
| 2005 | -805.47 Million EUR | -589.64% |
| 2004 | 164.5 Million EUR | -94.12% |
| 2003 | 2.79 Billion EUR | -46.75% |
| 2002 | 5.25 Billion EUR | -24.78% |
| 2001 | 6.98 Billion EUR | 137.21% |
| 2000 | 2.94 Billion EUR | 198.85% |
| 1999 | 985.83 Million EUR | 133.43% |
| 1998 | -2.94 Billion EUR | -214.84% |
| 1997 | 2.56 Billion EUR | -50.29% |
| 1996 | 5.16 Billion EUR | 27.42% |
| 1995 | 4.05 Billion EUR | -30.68% |
| 1994 | 5.84 Billion EUR | -9.35% |
| 1993 | 6.45 Billion EUR | -41.75% |
| 1992 | 11.07 Billion EUR | 108.31% |
| 1991 | 5.31 Billion EUR | -18.18% |
| 1990 | 6.49 Billion EUR | -39.81% |
| 1989 | 10.79 Billion EUR | -1.86% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.87 Billion EUR | -67.41% |
| 2024 Q2 | 6.45 Billion EUR | 245.03% |
| 2024 Q3 | -1.8 Billion EUR | -127.98% |
| 2023 Q4 | 5.74 Billion EUR | 493.39% |
| 2023 Q1 | 1.18 Billion EUR | -83.17% |
| 2023 Q2 | 7.25 Billion EUR | 513.36% |
| 2023 FY | 5.74 Billion EUR | -18.28% |
| 2023 Q3 | 968 Million EUR | -86.66% |
| 2022 Q2 | 6.74 Billion EUR | 192.54% |
| 2022 FY | 7.02 Billion EUR | 50.32% |
| 2022 Q4 | 7.02 Billion EUR | 455.21% |
| 2022 Q3 | 1.26 Billion EUR | -81.22% |
| 2022 Q1 | 2.3 Billion EUR | -50.71% |
| 2021 FY | 4.67 Billion EUR | 26.11% |
| 2021 Q1 | 3.22 Billion EUR | -13.0% |
| 2021 Q2 | 6.82 Billion EUR | 111.66% |
| 2021 Q3 | 1 Billion EUR | -85.31% |
| 2021 Q4 | 4.67 Billion EUR | 366.2% |
| 2020 Q1 | 1.42 Billion EUR | -64.55% |
| 2020 Q2 | 5 Billion EUR | 250.77% |
| 2020 Q4 | 3.7 Billion EUR | 61.64% |
| 2020 FY | 3.7 Billion EUR | -7.81% |
| 2020 Q3 | 2.29 Billion EUR | -54.14% |
| 2019 FY | 4.02 Billion EUR | 28.38% |
| 2019 Q4 | 4.02 Billion EUR | 158.98% |
| 2019 Q1 | 2.12 Billion EUR | -32.21% |
| 2019 Q2 | 4.74 Billion EUR | 123.21% |
| 2019 Q3 | 1.55 Billion EUR | -67.24% |
| 2018 Q4 | 3.13 Billion EUR | 93.87% |
| 2018 FY | 3.13 Billion EUR | 12.82% |
| 2018 Q1 | 1.94 Billion EUR | -30.1% |
| 2018 Q2 | 3.31 Billion EUR | 70.63% |
| 2018 Q3 | 1.61 Billion EUR | -51.21% |
| 2017 Q1 | 2.61 Billion EUR | -20.14% |
| 2017 FY | 2.77 Billion EUR | -15.13% |
| 2017 Q4 | 2.77 Billion EUR | -25.97% |
| 2017 Q3 | 3.75 Billion EUR | 454.88% |
| 2017 Q2 | 676 Million EUR | -74.13% |
| 2016 Q1 | 4.3 Billion EUR | 7.76% |
| 2016 Q4 | 3.27 Billion EUR | -16.3% |
| 2016 Q3 | 3.9 Billion EUR | 0.7% |
| 2016 Q2 | 3.88 Billion EUR | -9.8% |
| 2016 FY | 3.27 Billion EUR | -18.08% |
| 2015 Q3 | 4.52 Billion EUR | -0.51% |
| 2015 FY | 3.99 Billion EUR | 79.02% |
| 2015 Q1 | 4.11 Billion EUR | 84.58% |
| 2015 Q4 | 3.99 Billion EUR | -11.68% |
| 2015 Q2 | 4.54 Billion EUR | 10.37% |
| 2014 Q2 | 2.33 Billion EUR | 17.24% |
| 2014 Q1 | 1.99 Billion EUR | 38.58% |
| 2014 Q4 | 2.23 Billion EUR | -13.96% |
| 2014 Q3 | 2.59 Billion EUR | 11.14% |
| 2014 FY | 2.23 Billion EUR | 55.36% |
| 2013 Q2 | 2.1 Billion EUR | 36.98% |
| 2013 Q4 | 1.43 Billion EUR | -29.33% |
| 2013 FY | 1.43 Billion EUR | 105.14% |
| 2013 Q1 | 1.53 Billion EUR | 119.43% |
| 2013 Q3 | 2.03 Billion EUR | -3.42% |
| 2012 Q4 | 700 Million EUR | -52.19% |
| 2012 FY | 700 Million EUR | -1.82% |
| 2012 Q1 | 787 Million EUR | 10.38% |
| 2012 Q2 | 1.76 Billion EUR | 124.4% |
| 2012 Q3 | 1.46 Billion EUR | -17.1% |
| 2011 FY | 713 Million EUR | 160.68% |
| 2011 Q1 | -437 Million EUR | 62.81% |
| 2011 Q2 | 156 Million EUR | 135.7% |
| 2011 Q3 | 1.18 Billion EUR | 662.18% |
| 2011 Q4 | 713 Million EUR | -40.03% |
| 2010 Q3 | 80 Million EUR | -73.86% |
| 2010 Q4 | -1.17 Billion EUR | -1568.75% |
| 2010 Q1 | 74 Million EUR | 162.18% |
| 2010 FY | -1.17 Billion EUR | -887.39% |
| 2010 Q2 | 306 Million EUR | 313.51% |
| 2009 Q3 | 621 Million EUR | -26.07% |
| 2009 FY | -119 Million EUR | -120.95% |
| 2009 Q2 | 840 Million EUR | 57.3% |
| 2009 Q1 | 534 Million EUR | -0.74% |
| 2009 Q4 | -119 Million EUR | -119.16% |
| 2008 Q2 | 1.51 Billion EUR | 103.01% |
| 2008 Q3 | 1.49 Billion EUR | -1.34% |
| 2008 FY | 568 Million EUR | 110.88% |
| 2008 Q4 | 538 Million EUR | -64.05% |
| 2008 Q1 | 747.16 Million EUR | 114.31% |
| 2007 Q2 | -2.45 Billion EUR | -24.43% |
| 2007 Q1 | -1.97 Billion EUR | 8.47% |
| 2007 FY | -5.22 Billion EUR | -142.33% |
| 2007 Q4 | -5.22 Billion EUR | -610.92% |
| 2007 Q3 | 1.02 Billion EUR | 141.64% |
| 2006 Q4 | -2.15 Billion EUR | 35.87% |
| 2006 FY | -2.15 Billion EUR | -167.43% |
| 2006 Q3 | -3.35 Billion EUR | -267.08% |
| 2006 Q2 | 2.01 Billion EUR | 54.33% |
| 2006 Q1 | 1.3 Billion EUR | 261.73% |
| 2005 Q4 | -805.47 Million EUR | -96805.85% |
| 2005 Q1 | 1.28 Billion EUR | 681.73% |
| 2005 Q2 | 1.45 Billion EUR | 13.36% |
| 2005 FY | -805.47 Million EUR | -589.64% |
| 2005 Q3 | -831.19 Thousand EUR | -100.06% |
| 2004 Q1 | 3.03 Billion EUR | 8.28% |
| 2004 FY | 164.5 Million EUR | -94.12% |
| 2004 Q4 | 164.5 Million EUR | -94.88% |
| 2004 Q3 | 3.21 Billion EUR | -13.36% |
| 2004 Q2 | 3.7 Billion EUR | 22.35% |
| 2003 Q1 | 5.55 Billion EUR | 5.76% |
| 2003 FY | 2.79 Billion EUR | -46.75% |
| 2003 Q4 | 2.79 Billion EUR | -46.54% |
| 2003 Q3 | 5.23 Billion EUR | -3.59% |
| 2003 Q2 | 5.43 Billion EUR | -2.32% |
| 2002 Q3 | 10.42 Billion EUR | -1.75% |
| 2002 Q4 | 5.25 Billion EUR | -49.59% |
| 2002 Q1 | 7.21 Billion EUR | 3.28% |
| 2002 FY | 5.25 Billion EUR | -24.78% |
| 2002 Q2 | 10.61 Billion EUR | 47.05% |
| 2001 Q4 | 6.98 Billion EUR | -6.77% |
| 2001 Q1 | 4.48 Billion EUR | 52.39% |
| 2001 Q3 | 7.49 Billion EUR | 41.42% |
| 2001 FY | 6.98 Billion EUR | 137.21% |
| 2001 Q2 | 5.3 Billion EUR | 18.06% |
| 2000 Q4 | 2.94 Billion EUR | 71.88% |
| 2000 Q3 | 1.71 Billion EUR | 329.97% |
| 2000 FY | 2.94 Billion EUR | 198.85% |
| 2000 Q1 | 709.39 Million EUR | -28.04% |
| 2000 Q2 | -745.36 Million EUR | -205.07% |
| 1999 Q4 | 985.83 Million EUR | -40.31% |
| 1999 FY | 985.83 Million EUR | 133.43% |
| 1999 Q1 | -3.22 Billion EUR | -9.42% |
| 1999 Q2 | -161.3 Million EUR | 95.0% |
| 1999 Q3 | 1.65 Billion EUR | 1123.96% |
| 1998 Q1 | 1.39 Billion EUR | -45.7% |
| 1998 Q2 | 1.83 Billion EUR | 31.72% |
| 1998 Q4 | -2.94 Billion EUR | -262.42% |
| 1998 Q3 | 1.81 Billion EUR | -1.15% |
| 1998 FY | -2.94 Billion EUR | -214.84% |
| 1997 Q3 | 4.56 Billion EUR | -14.8% |
| 1997 Q4 | 2.56 Billion EUR | -43.76% |
| 1997 FY | 2.56 Billion EUR | -50.29% |
| 1997 Q1 | 4.99 Billion EUR | -3.25% |
| 1997 Q2 | 5.35 Billion EUR | 7.22% |
| 1996 FY | 5.16 Billion EUR | 27.42% |
| 1996 Q4 | 5.16 Billion EUR | 0.0% |
| 1995 FY | 4.05 Billion EUR | -30.68% |
| 1995 Q4 | 4.05 Billion EUR | 0.0% |
| 1994 FY | 5.84 Billion EUR | -9.35% |
| 1994 Q4 | 5.84 Billion EUR | 0.0% |
| 1993 Q4 | 6.45 Billion EUR | 0.0% |
| 1993 FY | 6.45 Billion EUR | -41.75% |
| 1992 FY | 11.07 Billion EUR | 108.31% |
| 1992 Q4 | 11.07 Billion EUR | 0.0% |
| 1991 FY | 5.31 Billion EUR | -18.18% |
| 1991 Q4 | 5.31 Billion EUR | 0.0% |
| 1990 FY | 6.49 Billion EUR | -39.81% |
| 1990 Q4 | 6.49 Billion EUR | 0.0% |
| 1989 FY | 10.79 Billion EUR | -1.86% |
| 1989 Q4 | 10.79 Billion EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | -7000.00 USD | 82057242.857% |
| SS Innovations International, Inc. | 1.18 Million USD | -484484.657% |
| Össur hf. | 395.08 Million USD | -1353.883% |
| Össur hf. | 395.08 Million USD | -1353.883% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| QHSLab, Inc. | 1.72 Million USD | -331928.879% |
| BrainsWay Ltd. | -10.32 Million USD | 55758.915% |
| BioElectronics Corporation | 14.82 Million USD | -38641.307% |
| AVITA Medical, Inc. | -26.23 Million USD | 21997.24% |
| Zecotek Photonics Inc. | 2.76 Million USD | -207831.365% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Wellstar International, Inc. | 51.36 Million USD | -11082.29% |
| Hamilton Thorne Ltd. | 18.12 Million USD | -31589.214% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 124505.182% |
| Escalon Medical Corp. | 315.68 Thousand USD | -1819429.533% |
| Aurora Spine Corporation | 1.9 Million USD | -301002.663% |
| NewCardio, Inc. | 2.41 Million USD | -237744.23% |
| Avitar, Inc. | 5.17 Million USD | -110977.656% |
| Vivos Inc. | -1.59 Million USD | 360838.987% |
| Theraclion SA | -5.86 Million EUR | 98044.679% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | -1178560.177% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 1061864.999% |
| Positron Corporation | 1.68 Million USD | -340410.291% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | -897123.823% |
| Nanomix Corporation | 11.38 Million USD | -50333.935% |
| Wellness Center USA, Inc. | 3.98 Million USD | -144023.059% |
| Stratec SE | 119.12 Million USD | -4721.852% |
| Heart Tronics, Inc. | 54.99 Thousand USD | -10444485.871% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | -6163386.92% |
| Electromedical Technologies, Inc. | 1.61 Million USD | -356483.7% |
| Lombard Medical, Inc. | 11.49 Million USD | -49869.552% |
| ALR Technologies Inc. | 19.14 Million USD | -29897.527% |
| MicroPort Scientific Corporation | 673.58 Million USD | -752.754% |
| Vycor Medical, Inc. | 1.05 Million USD | -545411.355% |
| VMS Rehab Systems, Inc. | 133.52 USD | -4301977131.875% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 41761.583% |
| Guided Therapeutics, Inc. | 1.46 Million USD | -391447.643% |
| SANUWAVE Health, Inc. | 30.14 Million USD | -18953.305% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | -910317.978% |
| United American Healthcare Corporation | -9.32 Million USD | 61684.647% |
| Odyssey Group International, Inc. | 2.1 Million USD | -272412.27% |
| IR-Med Inc. | -606 Thousand USD | 947954.785% |
| Polarean Imaging plc | -5.94 Million USD | 96694.051% |
| ECGI Holdings, Inc. | 3.17 Million USD | -181027.716% |
| Capital Group Holdings, Inc. | -3508.00 USD | 163740122.805% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | -2187107.274% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | -2651694.948% |
| Urologix, Inc. | 4.61 Million USD | -124363.705% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | -136355.757% |
| Nexeon MedSystems Inc. | 3.33 Million USD | -172327.923% |
| Qualis Innovations, Inc. | 6671.00 USD | -86103932.379% |
| Smith & Nephew plc | 2.77 Billion USD | -106.762% |
| NIOX Group Plc | -23.93 Million USD | 24100.936% |
| Fuse Medical, Inc. | 1.75 Million USD | -327101.16% |
| Broncus Holding Corporation | -81.42 Million USD | 7154.353% |
| Brain Scientific Inc. | 2.11 Million USD | -271384.957% |
| Pressure BioSciences, Inc. | 22.67 Million USD | -25229.531% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | -14520718.06% |